Number of the records: 1
Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1
SYS 0184391 LBL 00000naa--2200000-a-4500 005 20250607175316.6 008 221114s2022----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1 / $c Ye-Han Zhou ... [et al.] 300 $b ilustr., aj fareb., grafy, obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d000077277 $a karcinóm ezofageálnych skvamóznych buniek $2 mesh 650 12
$7 sllk_us_auth*d020360 $a terapia neoadjuvantná $2 mesh 650 12
$7 sllk_us_auth*d060890 $a antigén B7-H1 $2 mesh 650 22
$7 sllk_us_auth*d016896 $a výsledok liečby $2 mesh 653 2-
$a chemorádioterapia neoadjuvantná 653 2-
$a imunochemoterapia neoadjuvantná 653 2-
$a expresia PD-L1 653 2-
$a odpoveď na liečbu 653 2-
$a vyhodnotenie súboru pacientov retrospektívne 700 1-
$7 sllk_us_auth*0056968 $a Zhou, Ye-Han $4 aut 773 0-
$7 nnas $w sllk_us_cat*0184350 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2022 $g Vol. 69, no. 4 (2022), s. 785-793
Number of the records: 1